William (Bill) Hawkins
Bill Hawkins currently serves as President & CEO of Immucor, Inc., a private company, wholly owned by TPG. Immucor is a market leader in helping secure the world's blood supply through automation. Mr. Hawkins is aSenior Advisor to TPG. Prior to joining Immucor in 2011, Mr. Hawkins served as Chairman and CEO of Medtronic, one of the worlds' largest and most innovative medical technology companies.
Mr. Hawkins joined Medtronic from Novoste Corp., where he had been President and Chief Executive Officer. He previously held senior leadership positions at American Home Products, Johnson & Johnson, Guidant Corp., and Eli Lilly & Co.
Mr. Hawkins is the Chairman of the newly founded Medical Device Innovation Consortium ("MDIC"), and was recently elected as the 2013 President of the American Institute of Medical and Biological Engineering ("AMIBE"). He serves as a Director on the Board of AdvaMedDX, is the Chairman of the Board for KeraNetics and on the Board of Thoratec Corporation, a NYSE-listed medical device company. Mr. Hawkins became a member of the Duke University Board of Trustees in 2011 and serves on the Business and Finance Committee and the Medical Center Academic Affairs Committee. In 2012, he was appointed to the Duke University Health System board and currently serves on the Audit and Compliance Committee.
He has an MBA from University of Virginia's Darden School of Business and a BS in electrical and biomedical engineering from Duke University.